Mironid Limited: Cofounder

Adams, D. R. (Recipient)

Activity: Other

Description

Head of Research Chemistry for Mironid Limited, a drug discovery company with internationally leading expertise in cyclic nucleotide signalling pathways that is focused on development of therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer. The company was launched following a successful Scottish Enterprise Proof of Concept award hosted jointly between Strathclyde and Heriot-Watt Universities.
Period29 Apr 2014